Company led medicines recall: Respreeza 1,000 mg powder and solvent for solution for infusion

CSL Behring UK Ltd is recalling specific batches of Respreeza 1,000 mg powder and solvent for solution for infusion (EU/1/15/1006/001) due to a manufacturing deviation that occurred during the filling process.

Further details of the batches and description of the problem can be found on the MHRA website